神内循证先锋动脉硬化(修改).pptVIP

Slide 26.?CAMELOT: Study Design CAMELOT is a 2-year, placebo-controlled, multicenter, randomized, double-blind, comparative, parallel trial that will include 3000 patients with CAD.9 Following a 2- to 6-week placebo run-in period, patients will be randomized to treatment with amlodipine 5 to 10 mg/d, enalapril 10 to 20 mg/d, or placebo on top of standard-of-care therapies. CAMELOT will assess the effect of 2 years of therapy on clinical events (morbidity and mortality). Angiographically Inapparent Coronary Atherosclerosis: Diffuse Symmetrical Disease This slide provides an example of how ang